Endoscopy 2009; 41: E200-E201
DOI: 10.1055/s-0029-1214856
Unusual cases and technical notes

© Georg Thieme Verlag KG Stuttgart · New York

Complete esophageal obstruction: an ususual complication of esophageal variceal ligation

D.  Verma1 , C.  Pham1 , A.  Madan1
  • 1Division of Gastroenterology, The University of Texas Health Science Center, Houston, Texas, USA
Further Information

Publication History

Publication Date:
27 July 2009 (online)

A 65-year-old woman with cirrhosis presented having suffered from acute chest discomfort and difficulty swallowing for 1 day. Two weeks previously, she had undergone esophagogastroduodenoscopy (EGD) with endoscopic variceal ligation (EVL) for bleeding esophageal varices. Repeat EVL was done on the day before the present admission for continued variceal eradication. After the procedure, the patient developed acute retrosternal discomfort and inability to tolerate oral intake, which worsened with observation.

Gastrografin swallow on admission revealed complete esophageal obstruction at the level of the carina ([Fig. 1]).

Fig. 1 Gastrografin swallow study showing complete obstruction to the passage of contrast through the esophageal lumen.

Repeat EGD showed a necrotic, completely obstructing mass in mid esophagus which could not be traversed even with a slim endoscope. Three bands were noted in the periphery of the obstructive mass ([Fig. 2]).

Fig. 2 Endoscopic view of complete obstruction of the esophagus.

No intervention was performed due to the risk of perforation and the patient was put on total parental nutrition. The following week, she experienced gradual improvement of the dysphagia. Eventually, she was able to tolerate a full diet. An upper gastrointestinal series 2 weeks later showed complete resolution of the esophageal obstruction ([Fig. 3]).

Fig. 3 Resolution of esophageal obstruction with conservative treatment.

Variceal bleeding is a major complication occurring in 30 % – 60 % of patients with cirrhosis [1] [2]. The associated mortality is as high as 20 % within 6 weeks after the initial bleeding, and 60 % of untreated patients experience recurrent bleeding within a year [1]. EVL is the therapy of choice for primary bleeding prophylaxis and postbleeding management [3] [4]. The procedure is relatively safe, with very few reported complications; these include band site ulceration, bleeding, infection, transient dysphagia, and esophageal perforation caused by trauma [5].

Although transient dysphagia can occur following EVL, complete esophageal obstruction is rare. Our patient developed complete esophageal obstruction after EVL with significant dysphagia, and the follow-up examination demonstrated esophageal obstruction at the EVL site.

This obstruction occurred due to luminal compromise secondary to tissue edema and necrosis at the banding site. To avoid this, we recommend that EVLs should be applied in a spiral fashion, especially in patients needing multiple sessions, so as to avoid extensive luminal compromise on one plane.

Endoscopy_UCTN_Code_CPL_1AH_2AC

References

  • 1 D’Amico G, de Franchis R. Cooperative Study Group . Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators.  Hepatology. 2003;  38 599-612
  • 2 Carbonell N, Pauwels A, Serfaty L. et al . Improved survival after variceal bleeding in patients with cirrhosis over the past two decades.  Hepatology. 2004;  40 652-659
  • 3 Garcia-Tsao G, Sanyal A J, Grace N D, Carey W. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.  Hepatology. 2007;  46 922-938
  • 4 Lui H F, Stanley A J, Forrest E H. et al . Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate.  Gastroenterology. 2002;  123 735-744
  • 5 Lo G H, Chen W C, Chen M H. et al . Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding.  Gastroenterology. 2002;  123 728-734

A. MadanMD, FACP 

Division of Gastroenterology
The University of Texas Health Science Center

6431 Fannin Street, MSB 4.234
Houston
TX 77030
USA

Fax: +1-713-5006699

Email: anandmadan@hotmail.com

    >